Biosurgery Market Size Worth USD 27.66 Billion by 2034 | CAGR: 6.38%
The biosurgery market size is expected to reach USD 27.66 billion by 2034, according to a new study by Polaris Market Research. The report “Biosurgery Market Share, Size, Trends, Industry Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Attachments, Others), By Application, By Region; Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Biosurgery is a specialized medical field that utilizes natural biological organisms or substances to support surgical procedures, thereby promoting healing and minimizing complications. Surgeons employ maggot debridement, leeches, enzymes, or other biological agents to treat wounds, remove dead tissue, or improve blood flow. These methods offer a minimally invasive alternative to traditional surgery, benefiting patients who cannot undergo conventional procedures due to health risks.
Request a free sample copy or read the full market insights : Biosurgery Market Report
Biosurgery offers several advantages, including lower infection rates, reduced scarring, and faster recovery times compared to conventional surgery. It also benefits patients with compromised immune systems or those at high risk for anesthesia complications. However, practitioners must carefully select candidates, as some individuals may experience allergic reactions or psychological discomfort with certain biological agents.
Biosurgery Market Report Highlights
- North America dominated the global market with 40.4% revenue share in 2025. Rising prevalence of chronic diseases and an increasing aging population drive the share.
- The U.S. led the regional market with 81.8% share in 2025. It is due to high healthcare spending and a rising focus on minimally invasive procedures.
- The market in Asia Pacific is projected to register a CAGR of 7.47% from 2026 to 2034. The growth is attributed to the rapidly improving healthcare infrastructure and the rising number of surgical procedures.
- The surgical sealants segment accounted for 23.8% market share in 2025. The rising volume of elective and complex surgeries propelled the demand for surgical sealants.
- The cardiovascular surgery segment is projected to exhibit the highest CAGR of 6.40% during the forecast period. This is fueled by the increasing prevalence of heart diseases.
- A few global key market players include Artivion, Inc.; Aroa Biosurgery; B. Braun SE; Baxter; BD; INTEGRA LIFESCIENCES; Johnson & Johnson Services, Inc.; Medtronic; Pfizer Inc.; Sanofi; and Stryker.
Polaris Market Research has segmented the biosurgery market report on the basis of product, application, and region:
By Product Outlook (Revenue, USD Billion, 2021–2034)
- Surgical Sealants
- Hemostatic Agents
- Adhesion Barriers
- Soft Tissue Attachments
- Bone Graft Attachments
- Others
By Application Outlook (Revenue, USD Billion, 2021–2034)
- General Surgery
- Orthopedic Surgery
- Cardiovascular Surgery
- Neurological Surgery
- Others
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
